Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)
USD 2.16
(0.46%)
USD 2.16
(0.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.58 Billion CNY | -0.56% |
| 2022 | 3.6 Billion CNY | 41.19% |
| 2021 | 2.55 Billion CNY | 9.42% |
| 2020 | 2.33 Billion CNY | 0.58% |
| 2019 | 2.31 Billion CNY | 13.12% |
| 2018 | 2.05 Billion CNY | 2.73% |
| 2017 | 1.99 Billion CNY | -3.02% |
| 2016 | 2.05 Billion CNY | 4.82% |
| 2015 | 1.96 Billion CNY | -21.15% |
| 2014 | 2.49 Billion CNY | -7.32% |
| 2013 | 2.68 Billion CNY | 25.48% |
| 2012 | 2.14 Billion CNY | 10.48% |
| 2011 | 1.93 Billion CNY | 10.8% |
| 2010 | 1.74 Billion CNY | -6.88% |
| 2009 | 1.87 Billion CNY | -4.73% |
| 2008 | 1.97 Billion CNY | -7.27% |
| 2007 | 2.12 Billion CNY | 1.36% |
| 2006 | 2.09 Billion CNY | -0.41% |
| 2005 | 2.1 Billion CNY | 3.5% |
| 2004 | 2.03 Billion CNY | 3.95% |
| 2003 | 1.95 Billion CNY | 48.48% |
| 2002 | 1.31 Billion CNY | 11.91% |
| 2001 | 1.17 Billion CNY | -14.37% |
| 2000 | 1.37 Billion CNY | 348.34% |
| 1999 | 306.96 Million CNY | 39.19% |
| 1998 | 220.53 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 4.02 Billion CNY | 12.22% |
| 2024 Q3 | 4.51 Billion CNY | -19.22% |
| 2024 Q2 | 5.59 Billion CNY | 38.96% |
| 2023 Q2 | 3.97 Billion CNY | 1.03% |
| 2023 Q4 | 3.58 Billion CNY | -4.77% |
| 2023 Q1 | 3.93 Billion CNY | 9.12% |
| 2023 FY | 3.58 Billion CNY | -0.56% |
| 2023 Q3 | 3.76 Billion CNY | -5.28% |
| 2022 Q1 | 2.61 Billion CNY | 2.31% |
| 2022 Q3 | 2.87 Billion CNY | 6.66% |
| 2022 Q4 | 3.6 Billion CNY | 25.44% |
| 2022 FY | 3.6 Billion CNY | 41.19% |
| 2022 Q2 | 2.69 Billion CNY | 3.15% |
| 2021 Q3 | 2.74 Billion CNY | -2.58% |
| 2021 Q1 | 2.63 Billion CNY | 12.8% |
| 2021 Q4 | 2.55 Billion CNY | -6.84% |
| 2021 FY | 2.55 Billion CNY | 9.42% |
| 2021 Q2 | 2.81 Billion CNY | 6.89% |
| 2020 Q2 | 2.47 Billion CNY | 4.75% |
| 2020 FY | 2.33 Billion CNY | 0.58% |
| 2020 Q1 | 2.36 Billion CNY | 1.8% |
| 2020 Q3 | 2.23 Billion CNY | -9.72% |
| 2020 Q4 | 2.33 Billion CNY | 4.47% |
| 2019 FY | 2.31 Billion CNY | 13.12% |
| 2019 Q4 | 2.31 Billion CNY | 4.66% |
| 2019 Q3 | 2.21 Billion CNY | -4.76% |
| 2019 Q2 | 2.32 Billion CNY | 5.38% |
| 2019 Q1 | 2.2 Billion CNY | 7.69% |
| 2018 Q4 | 2.05 Billion CNY | -9.32% |
| 2018 FY | 2.05 Billion CNY | 2.73% |
| 2018 Q1 | 2.13 Billion CNY | 6.74% |
| 2018 Q2 | 2.27 Billion CNY | 6.7% |
| 2018 Q3 | 2.26 Billion CNY | -0.52% |
| 2017 Q2 | 2.38 Billion CNY | 20.08% |
| 2017 Q3 | 2.26 Billion CNY | -5.06% |
| 2017 FY | 1.99 Billion CNY | -3.02% |
| 2017 Q4 | 1.99 Billion CNY | -11.67% |
| 2017 Q1 | 1.98 Billion CNY | -3.69% |
| 2016 Q1 | 2.08 Billion CNY | 6.43% |
| 2016 FY | 2.05 Billion CNY | 4.82% |
| 2016 Q4 | 2.05 Billion CNY | 8.55% |
| 2016 Q3 | 1.89 Billion CNY | -6.7% |
| 2016 Q2 | 2.03 Billion CNY | -2.75% |
| 2015 Q1 | 2.6 Billion CNY | 4.74% |
| 2015 FY | 1.96 Billion CNY | -21.15% |
| 2015 Q4 | 1.96 Billion CNY | -9.57% |
| 2015 Q2 | 2.51 Billion CNY | -3.55% |
| 2015 Q3 | 2.17 Billion CNY | -13.68% |
| 2014 Q2 | 2.5 Billion CNY | 1.64% |
| 2014 Q4 | 2.49 Billion CNY | 2.47% |
| 2014 FY | 2.49 Billion CNY | -7.32% |
| 2014 Q3 | 2.43 Billion CNY | -3.04% |
| 2014 Q1 | 2.46 Billion CNY | -8.23% |
| 2013 Q2 | 2.23 Billion CNY | -2.9% |
| 2013 Q3 | 2.07 Billion CNY | -6.9% |
| 2013 Q1 | 2.29 Billion CNY | 7.27% |
| 2013 FY | 2.68 Billion CNY | 25.48% |
| 2013 Q4 | 2.68 Billion CNY | 29.4% |
| 2012 FY | 2.14 Billion CNY | 10.48% |
| 2012 Q1 | 2.02 Billion CNY | 4.39% |
| 2012 Q4 | 2.14 Billion CNY | 12.2% |
| 2012 Q3 | 1.9 Billion CNY | -10.02% |
| 2012 Q2 | 2.12 Billion CNY | 4.83% |
| 2011 FY | 1.93 Billion CNY | 10.8% |
| 2011 Q4 | 1.93 Billion CNY | -0.04% |
| 2011 Q1 | 1.92 Billion CNY | 9.97% |
| 2011 Q2 | 2.22 Billion CNY | 15.43% |
| 2011 Q3 | 1.93 Billion CNY | -12.68% |
| 2010 Q2 | 1.81 Billion CNY | -5.29% |
| 2010 FY | 1.74 Billion CNY | -6.88% |
| 2010 Q4 | 1.74 Billion CNY | -1.21% |
| 2010 Q3 | 1.77 Billion CNY | -2.44% |
| 2010 Q1 | 1.91 Billion CNY | 2.01% |
| 2009 Q3 | 1.88 Billion CNY | -4.11% |
| 2009 FY | 1.87 Billion CNY | -4.73% |
| 2009 Q2 | 1.96 Billion CNY | -1.58% |
| 2009 Q4 | 1.87 Billion CNY | -0.35% |
| 2009 Q1 | 1.99 Billion CNY | 1.3% |
| 2008 Q2 | 1.93 Billion CNY | -5.3% |
| 2008 FY | 1.97 Billion CNY | -7.27% |
| 2008 Q4 | 1.97 Billion CNY | 3.62% |
| 2008 Q3 | 1.9 Billion CNY | -1.46% |
| 2008 Q1 | 2.03 Billion CNY | -4.1% |
| 2007 Q4 | 2.12 Billion CNY | 7.1% |
| 2007 Q3 | 1.98 Billion CNY | -2.49% |
| 2007 Q2 | 2.03 Billion CNY | -7.44% |
| 2007 FY | 2.12 Billion CNY | 1.36% |
| 2007 Q1 | 2.2 Billion CNY | 4.86% |
| 2006 Q1 | 2.1 Billion CNY | -0.06% |
| 2006 Q4 | 2.09 Billion CNY | 0.62% |
| 2006 FY | 2.09 Billion CNY | -0.41% |
| 2006 Q3 | 2.08 Billion CNY | -3.11% |
| 2006 Q2 | 2.15 Billion CNY | 2.21% |
| 2005 Q2 | 2.11 Billion CNY | 4.41% |
| 2005 Q3 | 2.13 Billion CNY | 0.97% |
| 2005 Q4 | 2.1 Billion CNY | -1.38% |
| 2005 Q1 | 2.02 Billion CNY | -0.45% |
| 2005 FY | 2.1 Billion CNY | 3.5% |
| 2004 Q2 | 2.19 Billion CNY | 5.89% |
| 2004 FY | 2.03 Billion CNY | 3.95% |
| 2004 Q4 | 2.03 Billion CNY | -5.21% |
| 2004 Q3 | 2.14 Billion CNY | -2.27% |
| 2004 Q1 | 2.07 Billion CNY | 5.97% |
| 2003 Q2 | 1.49 Billion CNY | 2.53% |
| 2003 FY | 1.95 Billion CNY | 48.48% |
| 2003 Q3 | 1.69 Billion CNY | 13.4% |
| 2003 Q4 | 1.95 Billion CNY | 15.52% |
| 2003 Q1 | 1.45 Billion CNY | 10.56% |
| 2002 Q2 | 1.17 Billion CNY | 0.82% |
| 2002 Q3 | 1.08 Billion CNY | -8.09% |
| 2002 FY | 1.31 Billion CNY | 11.91% |
| 2002 Q1 | 1.16 Billion CNY | -0.79% |
| 2002 Q4 | 1.31 Billion CNY | 21.73% |
| 2001 FY | 1.17 Billion CNY | -14.37% |
| 2001 Q4 | 1.17 Billion CNY | 0.0% |
| 2001 Q2 | 1.09 Billion CNY | 0.0% |
| 2000 Q4 | 1.37 Billion CNY | 0.0% |
| 2000 FY | 1.37 Billion CNY | 348.34% |
| 1999 FY | 306.96 Million CNY | 39.19% |
| 1998 FY | 220.53 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|